Snook et al. described the mechanism of antigen-specific CD4+ T cell tolerance, where immunotherapeutic reactions are restricted to the inherent self-antigen guanylyl cyclase c (GUCY2C) in colorectal cancer [82]. Here, GUCY2C is linked to colorectal cancer.